The purpose of using Positive Quality Interventions (PQIs) is to create a more positive patient experience and better outcomes, explained Neal Dave, PharmD, pharmacy manager for Texas Oncology and chair of the PQI initiative for National Community Oncology Dispensing Association (NCODA).
The purpose of using Positive Quality Interventions (PQIs) is to create a more positive patient experience and better outcomes, explained Neal Dave, PharmD, pharmacy manager for Texas Oncology and chair of the PQI initiative for National Community Oncology Dispensing Association (NCODA).
Transcript
What are Positive Quality Interventions (PQI) and the purpose of NCODA's PQI initiative?
PQI stands for Positive Quality Interventions, and, basically, we try to create documents or create an intervention that pharmacy, nursing, pharmacy technicians can make that would create a positive impact for a patient.
For instance, the first PQI that we had at NCODA was based on, you get a prescription for aromatase inhibitor—this is a few years ago, and at that time a new drug had just come out that you could add on to the aromatase inhibitor—and, so, the advantage of NCODA pharmacists and nurses is we have access to the electronic medical record, we can look at the patient, we can look at the profile, we can say, “Hey, this person, we’re getting a prescription for an aromatase inhibitor, they’re probably a candidate for this other drug.” And the process is written down and there is backing for the pharmacist, so they don’t have to go look around for the data; they can take that 1 sheet, go to the physician and say, “Hey, should we get this other prescription sent to us?”
And that, ultimately, leads to a positive patient interaction and better patient outcomes. That’s an example of a PQI. Not all of them are exactly like that, but all of them are patient focused Our end goal is to take care of patients better and share information. That’s the main goals for the Positive Quality Interventions.
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, has been made in the fight against the HIV pandemic given the current political climate.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More